A Combined Strategy of TK1, HE4 and CA125 Shows Better Diagnostic Performance Than Risk of Ovarian Malignancy Algorithm (ROMA) in Ovarian Carcinoma.
Clinica Chimica Acta（2022）
关键词
Ovarian cancer,Algorithm,Thymidine kinase 1,Risk of Ovarian Malignancy Index,Risk of Ovarian Malignancy Algorithm,Tumor markers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要